Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Primary Axillary Hyperhidrosis

3 trials tracked for Primary Axillary Hyperhidrosis: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 1 Other / NA 1
  1. Phase 3 A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis Completed
  2. Phase 2 A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis Completed
  3. N/A Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
BoNTA injection reduces axillary sweat in Chinese patients with primary hyperhidrosis
Drug Pipeline RCT
BoNTA injection reduces axillary sweat in Chinese patients with primary hyperhidrosis One Shot Stops Excessive Underarm Sweating for Months, Study Finds
This Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 344 Chinese patients with primary axillary hyperhidrosis fo…
A single Botox shot safely cuts underarm sweat by more than half for up to four months in people with excessive sweating.
Apr 18, 2026